Jasper Therapeutics, Inc. (JSPR)
|Net Income (ttm)||-49.59M|
|Day's Range||13.61 - 14.55|
|52-Week Range||7.11 - 18.88|
|Est. Earnings Date||n/a|
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California. [Read more...]
Financial PerformanceFinancial Statements
Jasper Therapeutics Inc (NASDAQ: JSPR) is trading lower Thursday amid profit taking after the stock rallied roughly 120% on Wednesday. Jasper Therapeutics surged higher Wednesday after Oppenheimer analy...
There's loads of hot penny stocks worth checking in on today and we're taking a look at what some of the top movers are doing! The post Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving To...
Jasper Therapeutics (JSPR) stock is taking off on Wednesday thanks to a new bullish call from Oppenheimer analyst Jay Olson. The post JSPR Stock: The Bullish Call That Has Biotech Play Jasper Therapeuti...
A Wall Street investment bank just started following the company with a very upbeat outlook.
Jasper Therapeutics Inc (NASDAQ: JSPR) is surging higher Wednesday after Oppenheimer analyst Jay Olson initiated coverage on the stock with an Outperform rating and announced a price target of $21. The ...
Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business combination w...
Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Thera...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Amplitude Healthcare Acquisition Corp. - ...
NEW YORK, June 8, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action ...
Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs.
Biotech firm, Jasper Therapeutics Inc, is planning to go public via a reverse SPAC merger deal with Amplitude Healthcare Acquisition Corp (NASDAQ: AMHC) in a $100 million deal.
Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Lead...
REDWOOD CITY, Calif., & NEW YORK--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation...